title: Gemcitabine-induced hemolytic uremic syndrome: a case report.
authors.forename: T
authors.initials: T
authors.lastname: Brodowicz
authors.forename: S
authors.initials: S
authors.lastname: Breiteneder
authors.forename: C
authors.initials: C
authors.lastname: Wiltschke
authors.forename: C C
authors.initials: CC
authors.lastname: Zielinski
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine